| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 03/05/2003 | CN1399973A Health-care product for curing hysteromyoma and its preparation method |
| 03/05/2003 | CN1102596C 5H-thiazole [3,2-a] pyrmidine derivatives |
| 03/05/2003 | CN1102405C Chinese medicine composition for treating acyesis |
| 03/04/2003 | US6528541 Administering to the cow at least one of an ester of methionine, an ester of methionine amide, and an ester of hydroxy analogue of methionine, or salt of atleast one ester to increase milk production |
| 03/04/2003 | US6528521 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 03/04/2003 | US6528509 Pyrazole compositions useful as inhibitors of ERK |
| 03/04/2003 | US6528501 Control of fertility |
| 03/04/2003 | US6528263 Identifying a cell expressing protooncogene polypeptide by contacting a nucleic acid with a polynucleotide reagent and detecting its binding; can be used in diagnosis and treatment of cancer |
| 03/04/2003 | US6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation |
| 03/04/2003 | US6528086 Methods and apparatus for drug delivery involving phase changing formulations |
| 03/04/2003 | US6528060 Therapeutic compounds |
| 03/03/2003 | WO2002019971A1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 02/27/2003 | WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | WO2003016549A2 Nucleic-acid associated proteins |
| 02/27/2003 | WO2003016514A1 Mullerian inhibiting substance levels and ovarian response |
| 02/27/2003 | WO2003016468A2 Antagonistic anti-htnfsf13b human antibodies |
| 02/27/2003 | WO2003016331A2 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy |
| 02/27/2003 | WO2003016316A1 Diazacycloalkanes as oxytocin agonists |
| 02/27/2003 | WO2003016313A1 New compounds for treating impotence |
| 02/27/2003 | WO2003016270A2 Selective estrogen receptor modulators |
| 02/27/2003 | WO2003016267A1 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia |
| 02/27/2003 | WO2003015872A2 Intravaginal administration of an aromatase inhibitor for the treatment of oestrogen-dependent proliferative disorders |
| 02/27/2003 | WO2003015820A1 GnRH AGONIST COMBINATION DRUGS |
| 02/27/2003 | WO2003015805A1 Composition for removal of toxins |
| 02/27/2003 | WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | WO2003015797A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 02/27/2003 | WO2003015793A1 Delayed and sustained drug release |
| 02/27/2003 | WO2003015792A1 Anti-tumour 2-alkoxyestradiol sulfamates |
| 02/27/2003 | WO2003015770A1 Novel combination |
| 02/27/2003 | WO2003015761A1 Selective estrogen receptor modulators |
| 02/27/2003 | WO2003015759A2 Treatment of hyperproliferative conditions of body surfaces |
| 02/27/2003 | WO2003015757A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 02/27/2003 | WO2003015751A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 02/27/2003 | WO2003002123A3 Therapeutic combinations for the treatment of hormone deficiencies |
| 02/27/2003 | WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/27/2003 | WO2002089740A3 Sulfonamides |
| 02/27/2003 | WO2002080851A3 Chimeric vaccines |
| 02/27/2003 | WO2002074288A3 Treatment and prevention of sexual dysfunction resulting from ssri-therapy by using a tetrahydrobenz cd indole-6-carboxamide |
| 02/27/2003 | WO2002067869A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/27/2003 | WO2002064590A3 Carboline derivatives |
| 02/27/2003 | WO2002062321A3 Method for producing a floating tablet containing an active principle |
| 02/27/2003 | WO2002060388A3 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 02/27/2003 | WO2002053168A3 Sterilising pill |
| 02/27/2003 | WO2002046193A3 Heterocyclic ether substituted imidazoquinolines |
| 02/27/2003 | WO2002042436A3 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 02/27/2003 | WO2002028865A3 Condensed pyridoindole derivatives |
| 02/27/2003 | WO2002020767A3 G-csf analog compositions and methods |
| 02/27/2003 | WO2002002797A3 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 02/27/2003 | WO2001098267A8 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
| 02/27/2003 | WO2001092892A3 Methods to identify compounds that modulate rage |
| 02/27/2003 | US20030040625 For therapy of hypertension, type 2 insulin-resistant diabetes mellitus, ecalmpsia and preeclampsia |
| 02/27/2003 | US20030040536 For therapy of disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 02/27/2003 | US20030040533 For use as hypoglycaemic and hypolipidaemic agents |
| 02/27/2003 | US20030040530 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containning them |
| 02/27/2003 | US20030040523 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 02/27/2003 | US20030040483 Compounds with growth hormone releasing properties |
| 02/27/2003 | US20030040110 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 02/27/2003 | US20030040007 Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 02/27/2003 | US20030039701 Mixture containing animal extract from deer antlers |
| 02/27/2003 | US20030039626 Fat-binding polymers |
| 02/27/2003 | CA2493349A1 Delayed and sustained drug release |
| 02/27/2003 | CA2459434A1 Intravaginal administration of an aromatase inhibitor for the treatment of oestrogen-dependent proliferative disorders |
| 02/27/2003 | CA2458643A1 Nucleic-acid associated proteins |
| 02/27/2003 | CA2457918A1 Mullerian inhibiting substance levels and ovarian response |
| 02/27/2003 | CA2457632A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | CA2457453A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 02/27/2003 | CA2457452A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | CA2457041A1 Novel combination |
| 02/27/2003 | CA2456150A1 Selective estrogen receptor modulators |
| 02/27/2003 | CA2454671A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 02/27/2003 | CA2453962A1 Diazacycloalkanes as oxytocin agonists |
| 02/26/2003 | WO2002020467A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)-[n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient |
| 02/26/2003 | EP1285964A2 Human Mater proteins |
| 02/26/2003 | EP1285927A2 Use of glucocorticoid antagonists for the prevention and treatment of diseases of the male reproductive system |
| 02/26/2003 | EP1285665A1 Liquid gonadotropin containing formulations |
| 02/26/2003 | EP1285658A2 Treatments for female sexual dysfunction |
| 02/26/2003 | EP1285657A2 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 02/26/2003 | EP1285653A1 Use of alpha-1L agonists in the treatment of incontinence |
| 02/26/2003 | EP1285063A1 Anti-angiogenic polypeptides |
| 02/26/2003 | EP1285058A2 Fertilization of aged oocytes |
| 02/26/2003 | EP1284974A2 Triazolyl tropane derivatives as ccr5 modulators |
| 02/26/2003 | EP1284959A1 Compounds for modulating the rage receptor |
| 02/26/2003 | EP1284956A1 Il-8 receptor antagonists |
| 02/26/2003 | EP1284735A1 Apomorphine derivatives and methods for their use |
| 02/26/2003 | EP1284728A1 Pharmaceuticals for treating obesity |
| 02/26/2003 | EP1284727A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 02/26/2003 | EP1284724A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 02/26/2003 | EP0920431B1 Thienopyrimidines |
| 02/26/2003 | EP0850059B1 Pharmaceutical formulations containing darifenacin |
| 02/26/2003 | EP0770137B1 Improvements in production of proteins in host cells |
| 02/26/2003 | EP0754040B1 Rapamycin derivatives |
| 02/26/2003 | EP0655914B1 Use of Histamine-2 agonists for treatment of sexual dysfunction |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399633A 嘧啶衍生物 Pyrimidine derivatives |
| 02/26/2003 | CN1399630A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 02/26/2003 | CN1399626A Ethers of o-desmethyl venlafaxine |
| 02/26/2003 | CN1399622A Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 02/26/2003 | CN1399552A Method and composition for treatment of adenoviral ocular infections |
| 02/26/2003 | CN1399545A Treatment of certain cancers associated with weight gain |
| 02/26/2003 | CN1399533A Improved transdermal contraceptive delivery system and process |